Transgenic Knockout Mice with Exclusively Human Sickle Hemoglobin and Sickle Cell Disease
- 31 October 1997
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 278 (5339) , 876-878
- https://doi.org/10.1126/science.278.5339.876
Abstract
To create mice expressing exclusively human sickle hemoglobin (HbS), transgenic mice expressing human α-, γ-, and βS-globin were generated and bred with knockout mice that had deletions of the murine α- and β-globin genes. These sickle cell mice have the major features (irreversibly sickled red cells, anemia, multiorgan pathology) found in humans with sickle cell disease and, as such, represent a useful in vivo system to accelerate the development of improved therapies for this common genetic disease.Keywords
This publication has 16 references indexed in Scilit:
- Transgenic and gene knock-out mouse models of sickle cell anemia and the thalassemiasCurrent Opinion in Hematology, 1997
- Mouse model of human beta zero thalassemia: targeted deletion of the mouse beta maj- and beta min-globin genes in embryonic stem cells.Proceedings of the National Academy of Sciences, 1995
- Lethal α–thalassaemia created by gene targeting in mice and its genetic rescueNature Genetics, 1995
- Hypoxia-induced in vivo sickling of transgenic mouse red cells.Journal of Clinical Investigation, 1991
- Human Sickle Hemoglobin in Transgenic MiceScience, 1990
- A transgenic mouse model of sickle cell disorderNature, 1990
- A dominant control region from the human β-globin locus conferring integration site-independent gene expressionNature, 1989
- Sickle Cell Chronic Lung DiseaseMedicine, 1988
- A Specific Chemical Difference Between the Globins of Normal Human and Sickle-Cell Anæmia HæmoglobinNature, 1956
- Sickle Cell Anemia, a Molecular DiseaseScience, 1949